Vaccines | 2023 Notable Papers on mRNA Vaccines
It is our pleasure to present the highly viewed and cited papers published by Vaccines (ISSN: 2076-393X) in 2023 on the topic of mRNA vaccines. We would like to take this opportunity to acknowledge the exceptional individuals and teams whose work serves as an inspiration to fellow researchers and significantly impacts the field of mRNA-related research. We are grateful to our Section Editor-in-Chief, Prof. Dr. Hans-Peter Hartung, for his valuable assistance in selecting these papers. We invite you to explore the remarkable works listed below.
1. “Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study”
by Pietro Ferrara, Domenico Ponticelli, Lorenzo Losa, Claudia Romeo, Roberto Magliuolo, Andrea Vitale, Anna Zampella, Lucia Alleanza, Mario Borrelli, Beniamino Schiavone et al.
Vaccines 2023, 11(2), 247; https://doi.org/10.3390/vaccines11020247
Full text available online: https://www.mdpi.com/2076-393X/11/2/247
2. “Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation”
by Israel Henig, Jonathan Isenberg, Dana Yehudai-Ofir, Ronit Leiba, Shimrit Ringelstein-Harlev, Ron Ram, Batia Avni, Odelia Amit, Sigal Grisariu, Tehila Azoulay et al.
Vaccines 2023, 11(4), 775; https://doi.org/10.3390/vaccines11040775
Full text available online: http://www.mdpi.com/2076-393X/11/4/775
3. “Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines”
by Xiaojuan Yu, Chuanfei Yu, Xiaohong Wu, Yu Cui, Xiaoda Liu, Yan Jin, Yuhua Li and Lan Wang
Vaccines 2023, 11(5), 937; https://doi.org/10.3390/vaccines11050937
Full text available online: https://www.mdpi.com/2076-393X/11/5/937
4. “Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines”
by Cynthia M. Rohde, Claudia Lindemann, Michael Giovanelli, Rani S. Sellers, Jan Diekmann, Shambhunath Choudhary, Lila Ramaiah, Annette B. Vogel, Yana Chervona, Alexander Muik et al.
Vaccines 2023, 11(2), 417; https://doi.org/10.3390/vaccines11020417
Full text available online: https://www.mdpi.com/2076-393X/11/2/417
5. “Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models”
by Nicole Roth, Janina Gergen, Kristina Kovacikova, Stefan O. Mueller, Lorenz Ulrich, Jacob Schön, Nico Joel Halwe, Charlie Fricke, Björn Corleis, Anca Dorhoi et al.
Vaccines 2023, 11(2), 318; https://doi.org/10.3390/vaccines11020318
Full text available online: https://www.mdpi.com/2076-393X/11/2/318
6. “Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study”
by Tal Gazitt, Tali Eviatar, Jacqueline Shear, Roni Meidan, Victoria Furer, Joy Feld, Amir Haddad, Muna Elias, Nizar Hijazi, Nili Stein et al.
Vaccines 2023, 11(2), 476; https://doi.org/10.3390/vaccines11020476
Full text available online: https://www.mdpi.com/2076-393X/11/2/476
7. “Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods”
by Kangyang Lin, Han Cao, Ning Luan, Yunfei Wang, Jingping Hu and Cunbao Liu
Vaccines 2023, 11(5), 1003; https://doi.org/10.3390/vaccines11051003
Full text available online: https://www.mdpi.com/2076-393X/11/5/1003
8. “SARS-CoV-2 mRNA Dual Immunization Induces Innate Transcriptional Signatures, Establishes T-Cell Memory and Coordinates the Recall Response”
by Ioanna Papadatou, Maria Geropeppa, Kleio-Maria Verrou, Marianna Tzanoudaki, Theano Lagousi, Emmanouil Liatsis and Vana Spoulou
Vaccines 2023, 11(1), 103; https://doi.org/10.3390/vaccines11010103
Full text available online: https://www.mdpi.com/2076-393X/11/1/103
9. “Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines”
by Catharina Gerhards, Margot Thiaucourt, Michael Hetjens, Verena Haselmann, Michael Neumaier and Maximilian Kittel
Vaccines 2023, 11(3), 701; https://doi.org/10.3390/vaccines11030701
Full text available online: https://www.mdpi.com/2076-393X/11/3/701
10. “The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses”
by Lorena Usero, Lorna Leal, Carmen Elena Gómez, Laia Miralles, Elena Aurrecoechea, Ignasi Esteban, Berta Torres, Alexy Inciarte, Beatriz Perdiguero, Mariano Esteban et al.
Vaccines 2023, 11(2), 286; https://doi.org/10.3390/vaccines11020286
Full text available online: https://www.mdpi.com/2076-393X/11/2/286